Signos
Last verified 2026-06-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $57.0Mattributed |
|---|---|
| Latest round | series-b, $20.0M, 2026-01-01attributed |
| Founded | 2018 |
| Headquarters | Palo Alto, USA |
| Industry | healthtech |
| Stage | series-b+ |
| Website | signos.com |
Signos pairs a continuous glucose monitor with an AI app that gives real-time feedback on how food, movement and sleep affect glucose. It is built for consumers focused on weight management and metabolic health. It offers the first FDA-cleared CGM system for over-the-counter weight management.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-01 | series-b | $20.0M | gv |
Detected tech stack
amazon cloudfront, amazon web services
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $20.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $57.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | signos.com, read 2026-06-17 |
| Description | self-reported | signos.com, read 2026-06-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.